Natera names Solomon Moshkevich CEO, succeeding Steve Chapman
NTRA•Natera appointed Solomon Moshkevich CEO and a director, effective immediately, replacing Steve Chapman. Chapman will serve as a consultant for an extended period.
1. Leadership change
Moshkevich joined Natera in 2011 and most recently served as president of clinical diagnostics, after previously leading its oncology business. Chapman will serve as a consultant for an extended period.
